Literature DB >> 7876675

[A case of MRSA sepsis treated by the sequential combination therapy netilmycin and minocycline].

S Maesaki1, H Mashimoto, J Araki, S Asai, K Sawatari.   

Abstract

A sixteen year old female was feverish from June 12, 1993. Methicillin-resistant Staphylococcus aureus was isolated from the blood, the diagnosis of MRSA sepsis was established. Vancomycin (2 g/day) was administered for eighteen days, but MRSA was not eradicated in the blood culture. Then she was administered a combination therapy of arbekacin (200 mg/day) and imipenem/cilastain (1 g/day) for seven days, but MRSA in the blood was cultured continuously. The sequential combination therapy of netilmycin (200 mg/day) and minocycline (200 mg/day) was started, MRSA was eradicated from the blood culture after four days. The sequential combination therapy netilmycin and minocycline was seemed to be effective for MRSA infection.

Entities:  

Mesh:

Substances:

Year:  1994        PMID: 7876675     DOI: 10.11150/kansenshogakuzasshi1970.68.1523

Source DB:  PubMed          Journal:  Kansenshogaku Zasshi        ISSN: 0387-5911


  1 in total

1.  In vitro activity of sodium new houttuyfonate alone and in combination with oxacillin or netilmicin against methicillin-resistant Staphylococcus aureus.

Authors:  Xi Lu; Xinyi Yang; Xue Li; Yun Lu; Zhitao Ren; Longyin Zhao; Xinxin Hu; Jiandong Jiang; Xuefu You
Journal:  PLoS One       Date:  2013-07-02       Impact factor: 3.240

  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.